Search by Drug Name or NDC
NDC 00023-6150-04 Crinone 45 mg/1.125g Details
Crinone 45 mg/1.125g
Crinone is a VAGINAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Allergan, Inc.. The primary component is PROGESTERONE.
Product Information
NDC | 00023-6150 |
---|---|
Product ID | 0023-6150_da3178d8-d328-4d13-8e3f-18acc75e54d4 |
Associated GPIs | 55370060004010 |
GCN Sequence Number | 034383 |
GCN Sequence Number Description | progesterone, micronized GEL/PF APP 4 % VAGINAL |
HIC3 | G2A |
HIC3 Description | PROGESTATIONAL AGENTS |
GCN | 96805 |
HICL Sequence Number | 020653 |
HICL Sequence Number Description | PROGESTERONE, MICRONIZED |
Brand/Generic | Brand |
Proprietary Name | Crinone |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | progesterone |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | GEL |
Route | VAGINAL |
Active Ingredient Strength | 45 |
Active Ingredient Units | mg/1.125g |
Substance Name | PROGESTERONE |
Labeler Name | Allergan, Inc. |
Pharmaceutical Class | Progesterone [CS], Progesterone [EPC] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA020701 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00023-6150-04 (00023615004)
NDC Package Code | 0023-6150-04 |
---|---|
Billing NDC | 00023615004 |
Package | 6 APPLICATOR in 1 CARTON (0023-6150-04) / 1.125 g in 1 APPLICATOR |
Marketing Start Date | 1997-05-13 |
NDC Exclude Flag | N |
Pricing Information | N/A |